Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 69

Sort by

Sort Order Select

Journal Articles

Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade

Blood (2023) 142 (16): 1359–1370.

https://doi.org/10.1182/blood.2023020485

Published: 2023

Includes: Supplemental data

Journal Articles

Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice

Hua Jin, Xiong Ni, Ruishu Deng, Qingxiao Song, James Young, Kaniel Cassady, Mingfeng Zhang, Stephen Forman, Paul J. Martin, Qifa Liu, Defu Zeng

Blood (2016) 127 (18): 2249–2260.

https://doi.org/10.1182/blood-2015-09-668145

Published: 2016

Includes: Supplemental data

Journal Articles

Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia

Qifang Zhang, Dewan Md Sakib Hossain, Priyanka Duttagupta, Dayson Moreira, Xingli Zhao, Haejung Won, Ralf Buettner, Sergey Nechaev, Marcin Majka, Bin Zhang, Qi Cai, Piotr Swiderski, Ya-Huei Kuo, Stephen Forman, Guido Marcucci, Marcin Kortylewski

Blood (2016) 127 (13): 1687–1700.

https://doi.org/10.1182/blood-2015-08-665604

Published: 2016

Includes: Supplemental data

Journal Articles

Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells

Amy M. Cook, Liang Li, Yinwei Ho, Allen Lin, Ling Li, Anthony Stein, Stephen Forman, Danilo Perrotti, Richard Jove, Ravi Bhatia

Blood (2014) 123 (18): 2826–2837.

https://doi.org/10.1182/blood-2013-05-505735

Published: 2014

Includes: Supplemental data

Journal Articles

Leukemia cell–targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity

Dewan Md Sakib Hossain, Cedric Dos Santos, Qifang Zhang, Anna Kozlowska, Hongjun Liu, Chan Gao, Dayson Moreira, Piotr Swiderski, Agnieszka Jozwiak, Justin Kline, Stephen Forman, Ravi Bhatia, Ya-Huei Kuo, Marcin Kortylewski

Blood (2014) 123 (1): 15–25.

https://doi.org/10.1182/blood-2013-07-517987

Published: 2014

Includes: Supplemental data

Journal Articles

TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo

Qifang Zhang, Dewan Md Sakib Hossain, Sergey Nechaev, Anna Kozlowska, Wang Zhang, Yong Liu, Claudia M. Kowolik, Piotr Swiderski, John J. Rossi, Stephen Forman, Sumanta Pal, Ravi Bhatia, Andrew Raubitschek, Hua Yu, Marcin Kortylewski

Blood (2013) 121 (8): 1304–1315.

https://doi.org/10.1182/blood-2012-07-442590

Published: 2013

Includes: Supplemental data

Journal Articles

S1PR1 is an effective target to block STAT3 signaling in activated B cell–like diffuse large B-cell lymphoma

Yong Liu, Jiehui Deng, Lin Wang, Heehyoung Lee, Brian Armstrong, Anna Scuto, Claudia Kowolik, Lawrence M. Weiss, Stephen Forman, Hua Yu

Blood (2012) 120 (7): 1458–1465.

https://doi.org/10.1182/blood-2011-12-399030

Published: 2012

Includes: Supplemental data

Journal Articles

Pretreatment with Anti-CD3 Monoclonal Antibody Depletes Recipient CCR7 + Dendritic Cells and Prevents Graft-Versus-Host Disease While Preserving GVL Effects,

Can Liu, MD, Wei He, MD, Xiaofan Li, MD, Heather F Johnston, Miao Wang, MD, Jeremy Racine, Paul J Martin, MD, Stephen Forman, MD, Defu Zeng, MD

Blood (2011) 118 (21): 4024.

https://doi.org/10.1182/blood.V118.21.4024.4024

Published: 2011

Journal Articles

Tissue Parenchymal Cell Expression of B7-H1 Inhibits Infiltrating T Cell Expansion and Prevents Persistence of Graft-Versus-Host Disease

Xiaofan Li, MD, Wei He, MD, Ruishu Deng, MD, Can Liu, MD, Miao Wang, MD, James Young, Lieping Chen, MD, PhD, Yuan-Zhong Chen, MD, Paul J Martin, MD, Stephen Forman, MD, Defu Zeng, MD

Blood (2011) 118 (21): 2974.

https://doi.org/10.1182/blood.V118.21.2974.2974

Published: 2011

Journal Articles

Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies

Joseph Rosenthal, Jeffrey Wong, Anthony Stein, Dajun Qian, Debbie Hitt, Hossameldin Naeem, Andrew Dagis, Sandra H. Thomas, Stephen Forman

Blood (2011) 117 (1): 309–315.

https://doi.org/10.1182/blood-2010-06-288357

Published: 2011

Journal Articles

A Phase 2 Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) Plus Rituximab in Newly Diagnosed, Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

Mark Kirschbaum, MD, Leslie Popplewell, M.D., Maria L Delioukina, MD, Robert w Chen, Vinod Pullarkat, Paul Frankel, Joel Conrad, Joyce Hartshorn, Auayporn Nademanee, M.D., Stephen Forman, MD

Blood (2010) 116 (21): 3957.

https://doi.org/10.1182/blood.V116.21.3957.3957

Published: 2010

Journal Articles

An Engineered Cell Surface Polypeptide for Selection, Tracking and Ablation of Genetically Modified Hematopoietically Derived Cells Based on Human EGFR.

Xiuli Wang, MD, PhD, Wen-Chung Chang, MS, ChingLam W Wong, BS, David Colcher, PhD, Mark Sherman, PhD, Julie R Ostberg, PhD, Stanley R. Riddell, MD, Stephen Forman, MD, Michael C Jensen, MD

Blood (2010) 116 (21): 1469.

https://doi.org/10.1182/blood.V116.21.1469.1469

Published: 2010

Journal Articles

Comparative Analysis of Autologous Hematopoietic Cell Transplantation with Radioimmunotherapy (RIT) Based Conditioning Versus Total Body Irradiation (TBI) for High-Risk Diffuse Large Cell Lymphoma (DLCL): Toxicity and Efficacy

Amrita Krishnan, M.D., Joycelynne Palmer, PhD, Auayporn Nademanee, M.D., Andrew Raubitschek, MD, Dave Yamauchi, Neil Martin Kogut, MD, Laura Federico, Nicole Tsai, Stephen Forman, M.D.

Blood (2010) 116 (21): 32.

https://doi.org/10.1182/blood.V116.21.32.32

Published: 2010

Journal Articles

Extramedullary Relapse Following Reduced Intensity AlloHCT for Adult AML.

Neil Martin Kogut, MD, Joycelynne Palmer, PhD, Ni-Chun Tsai, MS, Joyce Collins, PhD, Margaret O'Donnell, M.D., F.R.C.P.C., Anthony Selwyn Stein, M.D., Ricardo Spielberger, MD, Stephen Forman, MD

Blood (2010) 116 (21): 3467.

https://doi.org/10.1182/blood.V116.21.3467.3467

Published: 2010

Journal Articles

siRNAs Against Cyclin D1/D2 Improves Cytotoxicity of Chemotherapy In Mantle Cell Lymphoma

Robert W Chen, Katrin Tiemann, PhD, Jessica Alluin, BS, Stephen Forman, John Rossi, PhD

Blood (2010) 116 (21): 1816.

https://doi.org/10.1182/blood.V116.21.1816.1816

Published: 2010

Journal Articles

Phase I Trial Results Testing Adoptively Transferred T Cells Expressing CD20-Specific Chimeric Antigen Receptors Containing CD28 and CD137 Costimulatory Domains In Patients with Mantle Cell Lymphoma and Indolent Lymphoma

Brian G. Till, MD, Michael C. Jensen, MD, Xiaojun Qian, Jinjuan Wang, Ajay K Gopal, MD, David G. Maloney, Catherine G. Lindgren, Yukang Lin, John M. Pagel, MD, PhD, Lihua E Budde, MD., PhD, Andrew Raubitschek, MD, Stephen Forman, Philip Greenberg, Stanley R. Riddell, MD, Oliver W. Press, MD, PhD

Blood (2010) 116 (21): 561.

https://doi.org/10.1182/blood.V116.21.561.561

Published: 2010

Journal Articles

Final Report of a Phase I Study of Clofarabine Plus High Dose Melphalan as a Conditioning Regimen for Allogeneic Transplantation

Mark Kirschbaum, MD, Anthony Selwyn Stein, M.D., Paul Frankel, Leslie Popplewell, M.D., Robert w Chen, Maria L Delioukina, MD, Ryotaro Nakamura, MD, David S. Snyder, MD, Cynthia Slape, Christopher Ruel, Joel Conrad, Auayporn Nademanee, M.D., Stephen Forman, MD

Blood (2010) 116 (21): 528.

https://doi.org/10.1182/blood.V116.21.528.528

Published: 2010

Journal Articles

Analysis of Risk Factors and Outcome for Extramedullary Relapses Post Allogeneic Stem Cell Transplantation for Myeloma.

Myo Htut, MD, Firoozeh Sahebi, M.D., George Somlo, MD, Pablo Parker, M.D., Chatchada Karanes, MD, Andy Dagis, Susan Hmwe, Tanya Paris, Joyce Murata-Collins, PhD, Leslie Popplewell, M.D., Joycelynne Palmer, PhD., Stephen Forman, M.D., Amrita Krishnan, M.D.

Blood (2010) 116 (21): 4562.

https://doi.org/10.1182/blood.V116.21.4562.4562

Published: 2010

Journal Articles

Aprepitant (Emend®) Significantly Increases Sirolimus Levels In Patients Undergoing Allogeneic Hematopoietic Stem Cell transplantation.

Sepideh Shayani, Pharm.D., Joycelynne Palmer, PhD, Tracey Stiller, Chan Holly, Pharm. D., Svetlana Keuylian, Pharm.D., Pablo Miguel Parker, M.D., Stephen Forman, MD, Ryotaro Nakamura, MD

Blood (2010) 116 (21): 1311.

https://doi.org/10.1182/blood.V116.21.1311.1311

Published: 2010

Journal Articles

Engraftment Fitness of Human Central Memory-Derived Effector CD8 + T Cells In Immunodeficient Mice

Xiuli Wang, MD, PhD, Berger Carolina, PhD, Stanley R. Riddell, MD, ChingLam W Wong, BS, Stephen Forman, MD, Michael C Jensen, MD

Blood (2010) 116 (21): 1019.

https://doi.org/10.1182/blood.V116.21.1019.1019

Published: 2010

NARROW

Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade

Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice

Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia

Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells

Leukemia cell–targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity

TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo

S1PR1 is an effective target to block STAT3 signaling in activated B cell–like diffuse large B-cell lymphoma

Pretreatment with Anti-CD3 Monoclonal Antibody Depletes Recipient CCR7 + Dendritic Cells and Prevents Graft-Versus-Host Disease While Preserving GVL Effects,

Tissue Parenchymal Cell Expression of B7-H1 Inhibits Infiltrating T Cell Expansion and Prevents Persistence of Graft-Versus-Host Disease

Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies

A Phase 2 Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) Plus Rituximab in Newly Diagnosed, Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

An Engineered Cell Surface Polypeptide for Selection, Tracking and Ablation of Genetically Modified Hematopoietically Derived Cells Based on Human EGFR.

Comparative Analysis of Autologous Hematopoietic Cell Transplantation with Radioimmunotherapy (RIT) Based Conditioning Versus Total Body Irradiation (TBI) for High-Risk Diffuse Large Cell Lymphoma (DLCL): Toxicity and Efficacy

Extramedullary Relapse Following Reduced Intensity AlloHCT for Adult AML.

siRNAs Against Cyclin D1/D2 Improves Cytotoxicity of Chemotherapy In Mantle Cell Lymphoma

Phase I Trial Results Testing Adoptively Transferred T Cells Expressing CD20-Specific Chimeric Antigen Receptors Containing CD28 and CD137 Costimulatory Domains In Patients with Mantle Cell Lymphoma and Indolent Lymphoma

Final Report of a Phase I Study of Clofarabine Plus High Dose Melphalan as a Conditioning Regimen for Allogeneic Transplantation

Analysis of Risk Factors and Outcome for Extramedullary Relapses Post Allogeneic Stem Cell Transplantation for Myeloma.

Aprepitant (Emend®) Significantly Increases Sirolimus Levels In Patients Undergoing Allogeneic Hematopoietic Stem Cell transplantation.

Engraftment Fitness of Human Central Memory-Derived Effector CD8 + T Cells In Immunodeficient Mice

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only